Shows
The Authority FileGenAI in Academic Libraries: Exploring AI-Driven Scholarship and Clarivate’s Web of Science Research AssistantIn this episode, Francesca Buckland, Vice President of Product Management for the Web of Science at Clarivate, joins The Authority File to discuss artificial intelligence applications in academic libraries. To start, Fran details Clarivate’s history with developing AI products, including seeking guidance from the library community. Further, she chats about generative AI enhancing research efficiencies and underpinning critical thinking, particularly through Clarivate’s recently launched Web of Science Research Assistant. As Fran explains, the tool offers scholarly overviews, visualizations, and guided research workflows, all based in the Web of Science Core Collection. Digging into the needed balance between automati...2024-12-1126 minThe Authority FileGenAI in Academic Libraries: Exploring AI-Driven Scholarship and Clarivate’s Web of Science Research AssistantIn this episode, Francesca Buckland, Vice President of Product Management for the Web of Science at Clarivate, joins The Authority File to discuss artificial intelligence applications in academic libraries. To start, Fran details Clarivate’s history with developing AI products, including seeking guidance from the library community. Further, she chats about generative AI enhancing research efficiencies and underpinning critical thinking, particularly through Clarivate’s recently launched Web of Science Research Assistant. As Fran explains, the tool offers scholarly overviews, visualizations, and guided research workflows, all based in the Web of Science Core Collection. Digging into the needed balance between automati...2024-12-1126 min
The Medical Alley Podcast (Presented by MentorMate)Market Access for Groundbreaking Treatments – A Case Study of Pulsed Field Ablation (PFA) with ClarivateNavigating the complexities of groundbreaking treatments can create headwinds. With innovations like Pulsed Field Ablation (PFA) at the forefront, challenges such as financial uncertainties, regulatory shifts, and global adoption become paramount. Join us for an insightful discussion on how global partners address these challenges, focusing on safety & efficacy, financial impacts, and clinical differentiation in areas where baseline data is scarce. Background on PFA: Pulsed Field Ablation (PFA) is a groundbreaking nonthermal energy source that is rapidly transforming atrial fibrillation (AF) treatment, affecting up to 38 million people worldwide. Unlike traditional heat or cold methods, PFA uses high-voltage electrical f...2024-10-0955 min
Ideas to InnovationNavigating the AI Frontier in Intellectual Property Law In this episode of Ideas to Innovation, we delve into the transformative influence of artificial intelligence (AI) on intellectual property (IP) and trademark law. Our conversation with guests Jay Myers, Director of Innovation for the Intellectual Property Practice Group at the Seyfarth Shaw international law firm, and Arun Hill, Senior Consultant, The Clarivate Center for IP and Innovation Research, unravels the complexities of integrating AI into legal practices. Our discussion illuminates AI's capacity to streamline trademark searches, enhance infringement monitoring, and inform strategic brand decisions. Yet, it also confronts the ethical dilemmas and practical challenges that accompany AI's...2024-04-1631 min
Ideas to InnovationPioneering Paths: The Tarpeyo Journey to FDA Approval and BeyondThe remarkable journey of Calliditas Therapeutics and its groundbreaking drug, Tarpeyo, sheds light on the company’s innovative strategies and relentless pursuit of excellence that led to the successful approval of Tarpeyo by the U.S. Food and Drug Administration (FDA) for the treatment of a specific kidney disease. Our guest in this episode, Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, reveals how their pioneering approach to drug development has set a new benchmark in the pharmaceutical industry. We explore how Calliditas Therapeutics' groundbreaking work in securing FDA approval not only marks a significant milestone for the comp...2024-03-0724 min
Against the Grain - The PodcastA Conversation with Bar Veinstein, President, Academia & Government, Clarivate Audio from the 2023 Charleston Conference Leadership Interview Series. Heather Staines, Senior Strategy Consultant, Delta Think and a Director for the Charleston Conference interviews Bar Veinstein, President, Academia & Government, Clarivate. Heather and Bar talk about his background and how he came to join Clarivate in a newly created position last year, how technology in libraries has changed and how libraries have been change agents as early adopters of technology ahead of other industries, not just in the libraries but beyond campus. He says Clarivate’s mission is to offer services to help libraries expand beyond the core for li...2024-02-1531 min
Ideas to InnovationInnovating Tomorrow: Unveiling 2023's Triumphs from Ideas to Reality Over the past year, the Ideas to Innovation podcast from Clarivate took listeners on a special journey through a world where curiosity meets ingenuity. In each of 15 episodes published in 2023, we told stories of people thinking forward in the real world, highlighting those who not only dared to dream but also transformed their dreams into reality. Our conversations with experts weren’t just talks; they were narratives of change, powerful examples of how fresh insights are solving some of the world’s most complex challenges. For this “Best of 2023” episode, we showcase three compelling stories, each of which ser...2023-12-1914 min
Ideas to InnovationFrom Lab to Life: The Transformative Power of Synthetic Biology Rapid advancements in technology and science are shaping a new era, with artificial intelligence and synthetic biology, or “syn-bio,” at the forefront. Heralded as the next big leap in science, syn-bio involves redesigning organisms for useful purposes by engineering them to have new abilities. The importance of syn-bio for people and our planet cannot be overstated. It offers novel ways of producing almost anything that human beings consume, from flavors and fabrics to foods and fuels. Today, the combination of syn-bio and AI – two of the most potent realms of science and technology – promises to unravel solutions to our most pre...2023-12-0721 min
Ideas to InnovationSilicon Healers: Unleashing the Power of Semiconductors to Drive Healthcare Innovation Over the past half century, the semiconductor technology landscape has been evolving rapidly, underpinning the digital transformations we witness across the various spheres of life today. Sometimes referred to as integrated circuits or microchips, semiconductors are the backbone of modern electronics. In devices of every type, from simple gadgets to complex systems like computers, cars and household appliances, semiconductors have led to them being smaller or faster or more reliable. More inconspicuously, semiconductors are now enabling innovations in healthcare to flourish. One company, imec, stands as a vanguard in this area. Their work promises to en...2023-11-2127 min
Ideas to InnovationTurning the Page: What Does the Future Hold for Academic Libraries? The concept of academic libraries has evolved from humble beginnings five thousand years ago to the expansive network that exists today in public schools, colleges, and universities across the United States. It’s easy to see why libraries are worth supporting. They continue to facilitate academic excellence, embrace advancements in technology and foster community and collaboration. Still, looking ahead, academic libraries face several significant challenges, including – perhaps most importantly – the significant cost for their support. Championing the cause of libraries is the mission of our latest guest on the “Ideas to Innovation Season 3” podcast from Clarivate. Jo...2023-10-2626 min
Ideas to InnovationThe Promise of AI in Life Sciences and Healthcare Artificial intelligence is all around us and it’s revolutionizing our world in many ways. In life sciences and healthcare, AI-powered technologies are instrumental in tasks such as diagnostics, precision medicine and even robotic surgery. And the transformative aspect of generative AI is already being felt in areas such as pharmaceutical research, epidemiology and telemedicine. There are projections that the global market for AI in life sciences and healthcare will be $6.7 billion USD by 2030. What is driving such remarkable growth and how rosy is this picture? Joining us at the start of a new season three...2023-09-1424 min
Against the Grain - The PodcastATGthePodcast 212 - A Conversation with Jonathan Adams, Chief Scientist, Institute for Scientific Information, a part of Clarivate In today’s episode, we’re talking with Jonathan Adams, Chief Scientist, Institute of Scientific Information, a part of Clarivate. Jonathan is interviewed by Matthew Ismail, a Conference Director and Editor in Chief of the Charleston Briefings. Jonathan Adams is a jack of all trades in the scholarly communication field. He is a scientist who taught in higher education and published a successful book in the field of biology. He has been an Assistant Secretary and Science Policy Advisor to the UK government. He has founded a startup related to his research and teaching. He has b...2023-08-2148 min
Ideas to InnovationThe Promise of AI to Help Reduce Early Deaths A person born this year is expected to live about 73 years, according to the World Health Organization. But 73 doesn’t reveal the full picture. According to a WHO report published in May, advances in science, related technologies and other factors have helped increase life expectancy worldwide by six years between 2000 and 2019. Good news, right? However, it’s also true that 80 percent of premature deaths could be avoided if patients and healthcare professionals had the right information at the right time to make better decisions. That’s where artificial intelligence comes in. Today, Patient Connect, a biopharma intelligence company that’s part of...2023-07-3125 min
Ideas to InnovationUniversity Students and Mental Health Among the consequences of COVID-19 is its adverse impact on the mental health and wellbeing among university students in the United States. Today’s students deal with many challenges from coursework, relationships and adjustments to campus life, to economic strain, social injustice, mass violence and various forms of loss related to the pandemic. In a 2021 survey, nearly 75 percent of college presidents listed students’ mental health as their most pressing issue. And key findings from a report released this year by non-profit Mental Health America shows more than 10 percent of young people are experiencing depression that severely impairs their ability to fu...2023-07-1121 min
Ideas to InnovationSeismic Shifts in the Global Research LandscapeSeason 2 Episode 16: Seismic shifts in the global research landscape with Jonathan Adams and David Pendlebury2023-05-2535 min
Ideas to InnovationHow Science and Big Data are Helping in the Search for an Effective Treatment of a Rare Disease that Causes Blindness Approximately 35,000 people worldwide have LHON, a genetic condition that affects the optic nerve, which sends visual information from the eye to the brain. In most cases, LHON – short for Leber’s hereditary optic neuropathy – leads to severe vision loss in both eyes, usually beyond the threshold of legal blindness and mostly among young men. In this episode of Ideas to Innovation Season 2, two special guests discuss the challenges of this rare disease on patients and their families. They help explain, too, the role and work of scientific research in seeking answers. Read more - https://clarivate.com/podcast...2023-05-0325 min
Conversations in HealthcareLighting the touch paper for next generation nucleic acid therapiesIn this episode Mike Ward, Clarivate’s Head of Thought Leadership for Life sciences and healthcare, spoke to Johnny Ohlson, Founder of Touchlight, a company who has developed a novel synthetic DNA vector. In recent years, we've seen that by harnessing the power of DNA, it has been possible to achieve success in treating previously incurable hereditary diseases and even tackle major pandemics. However, whether the answer is cell or gene therapies or RNA vaccines, one thing they all have in common is that they require DNA in some form or another as the starting material. Through Touchlight, Johnny Ohlson an...2023-05-0332 min
Ideas to InnovationSpotlight on Top 100 Global Innovators – A 3M Scientist’s Journey from Diamond-Like Coatings to Diapers Every year, Clarivate publishes a list of the Top 100 Global Innovators, companies and organizations that sit at the very top of the global innovation ecosystem, with the most consistent over-the-bar performance in innovation. Since the list began in 2012, only 19 companies can claim the distinction of being recognized continuously, year after year. One such company is 3M – the iconic global manufacturer and distributor well known for its cutting-edge scientific research and invention of groundbreaking products such as Post-it ® Notes, Scotchgard ™ Fabric Protector, and 2023-04-2022 min
Ideas to InnovationRecognizing the Vital Contributions of Black Women in Celebration of Women’s History Month From journalist Ida B. Wells to poet Maya Angelou to Aretha Franklin, the queen of soul music, Black women have made important contributions to the United States in a variety of areas, including politics, science, the arts, and social justice. Celebrating and recognizing Black women during Women’s History Month is an important way to honor their legacy and inspire future generations. In this episode we talk about how Black women have played a crucial role in advancing human rights and freedoms, contributing to our knowledge base, and improving our world with Dr. Ashley Farmer an associate pro...2023-03-1422 min
Ideas to InnovationWomen and Girls in Science - Career Opportunities and Challenges Ahead In February 2023, we celebrated women in science around the world for their significant contributions to science, technology, engineering and mathematics, collectively known as STEM. In this episode we discuss the achievements and challenges for women in science and for girls who are thinking about careers in STEM fields with Dr. Rachel Webster, Director, Healthcare Research and Data Analysis, Oncology and Biosimilars at Clarivate. Read more - https://clarivate.com/podcasts/ideas-to-innovation-season-two/ 2023-02-2325 min
Ideas to InnovationSecuring A Livable Earth – Experts’ Latest Look at Renewable Energy Most scientists agree that if the world is to achieve net zero by 2050 and secure a livable Earth, efforts to implement renewable energy need to be accelerated. Net zero refers to the balance between the amount of greenhouse gas produced and the amount removed from the atmosphere. We reach net zero when the amount we add is no more than the amount taken away. Of course, looking to build a better, more sustainable future has been talked about for years. But are we getting closer to achieving this shared global imperative? Addressing such questions are two guests: Ed...2023-02-0126 min
Ideas to InnovationEnd-Of-Year Holiday Special – “Ideas to Innovation Season 2”Since the first episode of Season 2 of our Ideas to Innovation podcast, in May 2022, we’ve taken listeners to places around the globe to hear compelling stories our guests have told, in their own authentic and passionate voices. Each episode has given us an inside look at how they’ve helped to drive change, find creative solutions to the toughest of challenges, and sometimes, even change the world. Through the lens of this podcast, we’ll share with you glimpses of the personal, and sometimes emotional, stories of the paths to innovation our guests have walked to improve lives and ou...2022-12-2922 min
Ideas to InnovationCitation Laureates: Energy Science and the Economics of Happiness In 2022, Clarivate named 20 world-class researchers from four countries as Citation Laureates. The impact of their work is immense and represents pioneering research worthy of recognition and celebration. We expect that some of these researchers will go on to receive a Nobel Prize, demonstrating once again the strong link between their substantial citation records and their influence on peers. In this episode, Daniel G. Nocera, Patterson Rockwood Professor of Energy at the Department of Chemistry and Chemical Biology at Harvard University and Andrew J. Oswald, a Professor of Economics and Behavioural Science at the University of Warwick share i...2022-12-1317 min
Ideas to InnovationUnder The Sea – The State of Ocean Research Today The fate of the Earth is closely tied to our oceans. Given the toll that humans have exacted on the marine environment within a relative handful of decades, the need for detailed scientific scrutiny of our ocean basins has never been more acute, and a new global report from Clarivate highlights the growing body of research in this area, particularly around sustainability and topics such as microplastics in the ocean. The report’s two authors, Ross Potter, Senior Data Scientist at the Institute for Scientific Information (ISI) and Brodie Pearson, Assistant Professor at Oregon State University in Corv...2022-11-2919 min
Ideas to InnovationTeaching ‘Hard History’ To Help Students Understand Past & Present The topic of civil rights in the United States is never far from the headlines. For almost 250 years, civil rights has remained a complex part of the fabric of America. Helping university students understand the history of civil rights, the important milestones in that ongoing struggle, and what it means for them has been a life’s work of the guest in this episode of Ideas to Innovation Season Two - Hasan Kwame Jeffries, Associate Professor in the Department of History at The Ohio State University. Read more - https://clarivate.com/podcasts/ideas-to-innovation-season-two/ Hosted on Ac...2022-11-0923 min
Ideas to InnovationSpotlight on Citation LaureatesThrough its Citation Laureates program, Clarivate recognises individuals whose research publications are highly cited and whose contributions to their fields have been extremely influential, even transformative. This year, we named twenty world-class researchers from four countries as Citation Laureates. These are researchers whose work is deemed to be ‘of Nobel class’, as demonstrated by analysis carried out by the ISI, and who are in the running for future Nobel honours. In this episode, you’ll hear from two of this year’s Citation Laureates who share insights into their work, how they got started, tips...2022-10-1916 min
Ideas to InnovationThe Future of Research IntegrityToday, with so much information available online, verification of information – who created it and who shared it – has become part of standard operating procedures in many enterprises to create a climate of trust surrounding information that can be used and acted upon. Nowhere is this truer than in the field of scientific research and reporting. In this episode, Nandita Quaderi, editor-in-chief for the Web of Science™ at Clarivate, shares her views on the topic of research integrity. She describes the importance of conducting and presenting research in a way that allows others to have trust and confidence in the...2022-09-2019 min
Ideas to InnovationDemocratization of Start-Ups in the Healthcare IndustryThe healthcare industry worldwide is changing. Hospitals and healthcare systems in many countries are struggling to control costs, increase revenues, train and retain skilled employees, and treat and care for patients. In the business of health care, new approaches and ideas are coming to the fore as part of this journey to transform healthcare and ultimately change patients' lives. In this episode, podcast host Neville Hobson joins guests Mike Ward, Global Head of Life Sciences and Healthcare Thought Leadership at Clarivate, and Jerry Harrison, Rock and Roll Hall of Fame inductee as a member of Talking Heads, and healthcare and...2022-08-2320 min
Ideas to InnovationThe Future of Sustainable MobilityWhile some say such manmade natural disasters are the new normal that we'll experience more strongly and more frequently in the future, others point the way to manmade solutions that help us take care of our environment through innovative efforts like reducing traffic pollution, and the emissions that contribute to climate extremes. In this podcast, our guest Ingrid Gogl, the vice president of marketing and communications at Yunex Traffic will put such manmade disasters in context as we consider how one company in Germany is initiating a mobility revolution that aims to protect our climate as much as it does...2022-08-1021 min
Conversations in HealthcareRealizing the patient-friendly future of clinical trialsIn this episode of Conversations in Healthcare, Ergomed founder Dr. Miroslav Reljanović talks to Mike Ward about how the COVID-19 pandemic has nudged clinical trials towards greater efficiency and inclusivity – and what’s needed to make good on this promising trend. Hosted on Acast. See acast.com/privacy for more information.2022-07-0523 min
Ideas to InnovationSustainability Leadership in PharmaEvery year, nearly 41 million people worldwide die prematurely from non-communicable diseases. Yet 80% of premature deaths could be avoided if patients and healthcare professionals alike had the right information at the right time to make better decisions. In this podcast Dr. Grace Lomax, the Clinical Director at Patient Connect, a part of Clarivate, shares her experience as a physician highlighting numerous unmet needs beyond just clinical issues – especially around healthcare literacy and education at the point of care. Hosted on Acast. See acast.com/privacy for more information.2022-06-1618 min
Ideas to InnovationThe Impact of Russia's Invasion of Ukraine on Global Scientific ResearchFor more than a decade, Ukraine has been a valuable part of scientific research with over 52,000 papers, many highly cited, written by Ukrainian researchers. This essential work came to a halt when Russia invaded Ukraine in February 2022. In this podcast Gali Halevi, Director at the Institute for Scientific Information at Clarivate, shares her perspectives on the impact on scientific research and discovery and how Clarivate is supporting displaced researchers in Ukraine. Hosted on Acast. See acast.com/privacy for more information.2022-05-2614 min
Ideas to InnovationIdeas to Innovation Season 2 - Coming SoonHave you ever thought about how innovation comes into the world? In Ideas to Innovation Season 2, we’ll continue talking to some remarkable people who have been on journeys to find creative solutions to the toughest of business challenges. Watch out for the first episode on your favorite podcast app. Hosted on Acast. See acast.com/privacy for more information.2022-05-1700 min
Conversations in HealthcareHow Patient Connect addresses unmet needs at the point of careIn this episode of Conversations in Healthcare, Mike Ward speaks with Dr. Grace Lomax, Clinical Director at Patient Connect, a part of Clarivate. Grace’s experience as a physician highlighted numerous unmet needs beyond just clinical issues – especially around healthcare literacy, education at the point of care, adherence and more. She discusses how Patient Connect uses technology and communication strategies to inform and support patients at the point of care, and shares examples of campaigns that improved outcomes in cancer, hypertension, rare disease and asthma. Hosted on Acast. See acast.com/privacy for more information.2022-04-1822 min
Ideas to InnovationTop 100 Global Innovators 2022: Accelerating Towards the Future with TE ConnectivityIn today’s episode, we look at the state of the global innovation landscape and the direction of ideas still to come, as revealed by Top 100 Global Innovators 2022 from Clarivate – an annual list that recognizes the organizations that demonstrate consistent, above-the-bar innovation excellence and which sit at the very top of the global innovation ecosystem. Joining us are Davy Brown, Vice President and Chief Technology Officer of Industrial Solutions for TE Connectivity and Ed White, Chief Analyst and Vice President of IP and Innovation Research, at Clarivate. Hosted on Acast. See acast.com/privacy for m...2022-03-1553 min
Ideas to InnovationLuxury Brands in a Changing WorldLuxury brands have a timeless appeal and consumers associate them with superior quality and exclusivity. In turn, these brands command premium prices for their products. Luxury brands are masters when it comes to the art of brand building, and they have consistently excelled at evoking quality and prestige. Joining us today to discuss how luxury brand owners are adapting to today's volatile and increasingly digital environment are several subject matter experts from Clarivate: Arun Hill, Analytics Consultant; Prudence Malinki, Senior Manager, Global Industry Relations; and David Marques, Principal Consultant, Litigation Products & Strategy. Hosted on...2022-02-1848 min
Conversations in HealthcareSocial determinants: barriers to healthcare impacting racial and ethnic minoritiesIn this episode of Conversations in Healthcare, Matthew Arnold, Principal Analyst at Clarivate speaks with Dr. Kenton Johnston, Associate Professor of Health Management and Policy at Saint Louis University about disparities in the US health system. Matthew and Ken discuss both the historical context as well as the evolution of the system since the establishment of the Affordable Care Act, and how the entire spectrum of the healthcare system can work to address social determinants of health. Learn more in the full episode. Hosted on Acast. See acast.com/privacy for more...2022-02-1045 min
Ideas to InnovationHighly Cited Researchers 2021: National University of Singapore and University of the WitwatersrandClarivate recently unveiled its annual list of Highly Cited Researchers, the “who’s who” of the world’s influential scientists and social scientists. The list from the Institute for Scientific Information recognizes some 6,600 researchers for demonstrating significant influence among their peers, as evidenced by the production of multiple highly cited papers that rank in the top 1% by citations for field and year, as indexed in the Web of Science over the last decade. Joining us today are David Pendlebury, Head of Research Analysis at the Institute for Scientific Information; Professor Liu Bin, Vice President of Research and Technology at the National...2022-01-2838 min
Ideas to InnovationInnovation in 2022 and BeyondTwo years into a global pandemic, innovation, at speed, continues unabated. Collaboration across borders remains strong, thanks to technological advancements in connectivity and mobile communications. Social interaction is evolving, as the physical and virtual world collide with the rise of the metaverse. Expertise at a distance, including remote medicine, is becoming more pervasive. Sustainability sits at the core of the agenda for businesses, government and society. As the world continues its tentative recovery, what does 2022 and beyond hold for us? Joining us today are Zaid Al-Nassir, Principal Analyst for Medical Technology, Lin Wang, Portfolio Marketing Manager...2022-01-0648 min
Common StacksEpisode 001: Intro and Clarivate buys ProQuest[[:encoded, "In this episode we introduce the podcast, break down the Proquest acquisition by Clarivate, and talk about the differences between a non-profit and profit when it comes to resources."]]2021-12-2031 min
Ideas to InnovationHighly Cited Researchers 2021: University of New South Wales & Van Andel InstituteClarivate recently unveiled its annual list of Highly Cited Researchers, the “who’s who” of the world’s influential scientists and social scientists. The list from the Institute for Scientific Information recognizes some 6,600 researchers for demonstrating significant influence among their peers, as evidenced by the production of multiple highly cited papers that rank in the top 1% by citations for field and year, as indexed in the Web of Science over the last decade. An outstanding faculty is the lifeblood of every notable research institution, and this year Highly Cited Researchers are based at more than 1,300 institutions all over the wor...2021-12-1534 min
Conversations in HealthcareHow Novo Ventures prioritized their investment strategy during the pandemicIn this episode of Conversations in Healthcare, Mike Ward speaks with Naveed Saddiqi, Senior Partner at Novo Ventures, one of the largest venture capital groups in the life sciences sector. Naveed shares about the firm’s mandate to generate funds for the Novo Nordisk Foundation, how the pandemic impacted their investment strategy and what excites him most in the life sciences industry. Learn more in the full episode, which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021). Hosted on Acast. See acast.com/privacy for more information.2021-12-1325 min
Ideas to InnovationTop 100 Global Innovators - Talking Innovation with Ericsson and AbbottIt has been a decade since the Clarivate Top 100 Global Innovators was conceived. Every year, for the last decade, Clarivate has honored the companies and institutions across the world that represent innovation at its finest. Today, we welcome guests from two of this year’s Top 100 Global Innovators to talk about creating and sustaining an innovative company through fast changing and challenging times. We also talk about the sustainability agenda, how it must work hand in hand with, not just the cycle of innovation, but indeed, be an integral part of companies’ fabric if we are to s...2021-12-0653 min
Conversations in HealthcareHow Healx uses AI to transform rare disease drug discoveryIn this episode of Conversations in Healthcare, Mike Ward speaks with Dr. Tim Guilliams, the co-founder and CEO of Healx. Healx is an artificial intelligence-powered technology company that's dedicated to helping rare disease patients access life improving treatments. Mike and Tim discuss the company’s innovative approach to drug discovery, choosing which rare diseases to target and how patients are shaping their priorities. Learn more in the full episode, which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021). Hosted on Acast. See acast.com/privacy for more information.2021-12-0127 min
Conversations in HealthcareHow the pandemic shifted Roche’s priorities and R&D investments In this episode of Conversations in Healthcare, Mike Ward speaks with Richard Erwin, general manager and managing director of Roche Products Limited (UK), which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021). Richard shares how the pandemic has shifted Roche’s priorities and why the organization has heavily increased their investment in R&D. Learn more in the full episode. Hosted on Acast. See acast.com/privacy for more information.2021-11-1531 minConversations in HealthcareOptimizing patient-first clinical trials with advanced site intelligenceIn this episode of Conversations in Healthcare, Mike Ward speaks with Oriol Serra, former Head of Site Intelligence and Selection at Pfizer and Simon Andrews, Vice President of RWD Engagements and Innovations at Clarivate about optimizing patient-first clinical trial design and ensuring trial groups align to real-life populations and needs. The group discusses the ins and outs to bring clinical trial management in-house, how to modernize trial designs with emerging data and intelligence, overcoming key challenges and advice for other pharma and biotechs looking to go down this path. Learn more in the full episode. Hosted on Acast...2021-11-0240 min
Ideas to InnovationCitation Laureates – Nobel Prize edition: Identifying the Giants of ResearchActors have their Oscars, and researchers have their Nobels. The Nobel prize has been the global pinnacle symbol of achievement in science since 1901 and economics since 1969. Each year since 2002, the Institute for Scientific Information (ISI)™ at Clarivate has identified a small group of Citation Laureates™: exceptionally highly cited scientists and economists whose influence is comparable to past and future Nobel prize winners. So far, 64 Citation Laureates have gone on to win a Nobel Prize, including five this year in 2021. Joining us are David Pendlebury, Head of Research Analysis at the Institute for Scientific Information, and David Audretsch...2021-10-2038 minConversations in HealthcareShowing the value of regulatory intelligence in pharmaIn this episode of Conversations in Healthcare, Mike Ward speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca, and Céline Rodier, Senior Health Policy Manager at Clarivate, about strategies and tools to gather and assess regulatory intelligence, as well as KPIs and approaches to demonstrating ROI within your organization. Get actionable takeaways in the full episode. Hosted on Acast. See acast.com/privacy for more information.2021-10-1131 min
Ideas to InnovationCOVID-19: Fighting a Global Pandemic with InnovationCOVID-19 is an enormous global challenge that has required an unprecedented level of engagement by stakeholders within pharma, research and policy. While SARS-CoV-2 emerged as a novel virus to which humans had no immunity, infection control measures have been deployed and existing as well as new and emerging technologies are being leveraged to speed the development of new treatments and therapies. Clarivate partnered with pharma in an international effort to bring life-saving vaccines to market. Joining us in this new episode of Ideas to Innovation are Clarivate experts Danielle Waterman, Senior Quality Specialist, Lynn Yoffee, Publisher...2021-09-2945 minConversations in HealthcareOvercoming health inequity in the U.S. and the role of telehealth: Ideas and best practices from Cigna, Henry Ford Health System and the eHealth InitiativeIncreased reliance on telehealth services has been one of the most significant care delivery shifts prompted by the COVID-19 pandemic. However, the pandemic has also thrown more light on the challenges of health inequity in the United States, especially among African American and Hispanic communities. We discuss these issues and potential solutions with leaders at the eHealth Initiative, Cigna and Henry Ford Health System. Panelists include:Wanneh Dixon, who is Director of Programs, Strategy & Development at eHealth Initiative Will M. Lopez, the National Medical Director-Virtual Care and Senior Medical Director-Behavioral Health at Cig...2021-09-2136 min
Scribble TalkScribble Talk Episode 123 - Chris Colquitt, Head of global proposal management, Clarivate (Electric Motorcycle Enthusiast, Trained in Martial Arts and Marathoner)With Scribble Talk reaching the 20k downloads' mile stone, we are excited to kick-off the hunt for our Super Fan through our latest campaign and shower our biggest fan with amazing prizes.You are invited to take the SCRIBBLE TALK SUPER FAN QUIZ and win a chance to get life time access to all podcast seasons and grab amazing Amazon Voucher Cards.Take the quiz now: https://baachuscribble.com/scribble-talk-super-fan-contest-2022/Chris Colquitt currently directs the operational and strategic proposal center at Clarivate, a global provider of Scientific and...2021-09-0954 min
Ideas to InnovationTop 100 Global Innovators with ThalesOver the past decade, Clarivate has identified the Top 100 Global Innovators, the companies and institutions at the pinnacle of the global innovation landscape that have contributed new ideas, solved some of the world’s most complex challenges and created new value. Today, we have a guest speaker from Thales, one of those 100 companies join us to talk about how businesses today go about creating and sustaining an innovative company, the complexity of modern-day innovation and how it continues to fascinate and inspire. Our guest speaker is Bernhard Quendt, Chief Technical Officer and Senior Vice President at Th...2021-09-0847 min
Ideas to InnovationThe Road Ahead: Sustainable Vehicles Today and in the Future - Part 2In a new report from Clarivate, The road ahead: sustainable vehicles today and in the future, we look at the fascinating history of the electric vehicles, the innovation spark that finally fueled its mass market production and wider consumer acceptance, and the state of innovation in the electric vehicles sector today. Today, we have subject matter experts from Clarivate talking about the new report and the electric vehicles which count among the handful of modern-day inventions that have truly captured our imagination. Our speakers today are Ed White, Head of Analytics, Robert Reading, Director of...2021-08-2531 minConversations in HealthcareBest practices for university - healthcare partnerships: Learnings from the Institute of Cancer ResearchIn this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Toby Richardson, who is Head of Business Development and Licensing; Deputy Director of Business and Innovation at The Institute of Cancer Research. Mike and Toby discuss how research collaborations between the ICR and biopharma companies help the Institute achieve its mission to make the discoveries that defeat cancer. Learn more in the full episode. Hosted on Acast. See acast.com/privacy for more information.2021-08-1927 min
Ideas to InnovationThe Road Ahead: Sustainable Vehicles Today and in the Future - Part 1In a new report from Clarivate, The road ahead: sustainable vehicles today and in the future, we look at the fascinating history of the electric vehicles, the innovation spark that finally fueled its mass market production and wider consumer acceptance, and the state of innovation in the electric vehicles sector today. Today, we have subject matter experts from Clarivate talking about the new report and the electric vehicles which count among the handful of modern-day inventions that have truly captured our imagination. Our speakers today are Ed White, Head of Analytics, Robert Reading, Director of...2021-08-1137 minConversations in HealthcareBest practices for university – healthcare partnerships: Learnings from OxfordIn this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Phil Clare, the Deputy Director, Research Services (Knowledge Exchange and Engagement) at the University of Oxford. Mike and Dr. Clare discuss the key role that university research plays in shaping new medicines and technologies, and what that process looks like. Learn more in the full episode. Hosted on Acast. See acast.com/privacy for more information.2021-07-3135 min
Ideas to InnovationTop 100 Global Innovators with Boston ScientificEvery year since 2012, Clarivate identifies the Top 100 Global Innovators. These are companies and institutions at the pinnacle of the global innovation landscape that have contributed new ideas, solved some of the world’s most complex challenges and created new value. Today, we have a guest from Boston Scientific, one of those 100 companies and institutions join us to talk about the value of innovation culture, how businesses today go about creating and sustaining an innovative company and embracing the sustainability imperative. Our guest speaker is David Knapp, Vice President of Research and Development for Peripheral Interventions at...2021-07-2849 min
Ideas to InnovationJournal Citation Reports 2021: The Evolution of Journal IntelligenceFor almost 50 years, the global research community has relied on the data in the Journal Citation Reports (JCR)™ to identify the world’s leading journals. The JCR is based on data from the Web of Science™, the world's largest publisher-neutral global citation database, and its journal intelligence metrics play a key role for funders, institutions, librarians and researchers. Academic publishers across the globe use the reports to evaluate their journals’ impact in their field and promote them to the research community – so each year’s update is met with great anticipation. In this episode we welcome guests from the Institu...2021-07-0737 min
Ideas to InnovationDrugs to Watch: Innovation in Alzheimer’s Disease ResearchOn June 7th, the U.S. Food and Drug Administration approved aducanumab, the first new Alzheimer’s treatment since 2003. Aducanumab is a monoclonal antibody that has been shown to reduce the build up of a protein known as beta amyloid that some think might be one of the possible causes of Alzheimer’s disease. While the approval has been applauded by some, it is not without controversy. We will be asking our guests how innovation in the search for treatments of Alzheimer’s disease is evolving. Our guest speakers are Mei Mei Hu, Chief Executive Officer at Vax...2021-06-2351 min
Conversations in HealthcareThe evolution of the asset-centric approach in biotech venture capitalIn this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Francesco De Rubertis, a co-founder and managing partner at Medicxi, one of the most prominent financial supporters of innovative biotech activity. Francesco provides insights into how the biotech venture capital model has evolved in the past decades to an asset-centric approach, and discusses Centessa, which recently secured $250m in funding. Learn more in the full episode. Hosted on Acast. See acast.com/privacy for more information.2021-06-1147 min
Conversations in HealthcareDrugs to Watch 2021Clarivate market experts break down the opportunities and potential threats for 2021’s Drugs to Watch – the key drugs expected to be blockbusters by 2026. Hosted on Acast. See acast.com/privacy for more information.2021-06-0323 min
Ideas to InnovationThe Value of Innovation Culture: a Conversation with Top 100 Global InnovatorsWelcome to the ‘Ideas to Innovation’ podcast. In this brand-new series, we'll engage in conversation with experts and industry leaders to discuss innovation at its core. In this episode we have guests from three of the Top 100 Global Innovator companies and institutions join us to talk about the value of innovation culture and how businesses today go about creating and sustaining an innovative company. We will be asking our guests how innovation is helping the world overcome the pandemic and deliver green shoots of recovery. Our guest speakers are Catherine Maresh, Vice President and Chief Intellectual Prop...2021-05-2146 min
Ideas to InnovationIdeas to Innovation - trailerIntroducing the 'Ideas to Innovation' podcast from Clarivate. Learn more about Clarivate and what’s coming up in the episodes that will follow. Hosted on Acast. See acast.com/privacy for more information.2021-05-1100 min
CISO to CISO Cybersecurity TalkEpisode 13 - Chris Houlder - Head of Global CyberSecurity at BioMarin Pharmaceutical Inc., Former CISO at Clarivate Analytics and AutodeskOn this episode of CISO to CISO we would like to welcome Chris Houlder, Head of Global CyberSecurity at BioMarin Pharmaceutical Inc. With nearly 25 years of experience spanning information security, team management, information technology and product/software security, Chris has been developing and executing strategies to solve complex security challenges and leading operational and company changes. Previously, Chris served as CISO and lead teams at Clarivate Analytics and Autodesk. Chris current serves as a board member for Rapticore, also a venture advisor for YL Ventures.2021-04-1443 min
Inside the ICE HouseClarivate CEO Jerre Stead Raises the Value of Companies by Trusting PeopleDuring his 41 years at the top of a corporate organizational chart, Jerre Stead, Chairman and CEO of Clarivate (NYSE:CCC), has led 11 public companies, employed over 400,000 people, and completed 200 acquisitions. He leaned on all that experience to make sure his current company thrived as it completed five acquisitions & transitioned to a remote environment. He joins the podcast to discuss Clarivate’s mission to fuel life-changing innovations while growing at “Jerre Speed” through good work & smart deals. Inside the ICE House: https://www.theice.com/insights/conversations/inside-the-ice-house2021-01-041h 05Inside the ICE HouseClarivate CEO Jerre Stead Raises the Value of Companies by Trusting PeopleDuring his 41 years at the top of a corporate organizational chart, Jerre Stead, Chairman and CEO of Clarivate (NYSE:CCC), has led 11 public companies, employed over 400,000 people, and completed 200 acquisitions. He leaned on all that experience to make sure his current company thrived as it completed five acquisitions & transitioned to a remote environment. He joins the podcast to discuss Clarivate’s mission to fuel life-changing innovations while growing at “Jerre Speed” through good work & smart deals. Inside the ICE House: https://www.theice.com/insights/conversations/inside-the-ice-house2021-01-041h 05Conversations in HealthcareUtilizing pluripotent stem cells in cell therapyIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Brian Culley, CEO of Lineage Cell Therapeutics. Brian and Mike discuss the company’s cell therapy program, utilizing pluripotent stem cells, initially targeting dry age-related macular degeneration, acute spinal cord injuries, and non-small cell lung cancer. Brian shares about the status of their Phase 1/2a clinical trials, and how COVID-19 has affected the company’s operations. Hosted on Acast. See acast.com/privacy for more information.2020-12-0225 minConversations in HealthcarePivoting a product launch during the pandemicIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Bryan Witherbee, President & CEO of Adarza BioSystems. Earlier this year, Adarza raised 25 million dollars to support the full commercialization of Ziva, an automated biological platform which delivers comprehensive, high definition, protein biomarker profiles. Although their launch plans were disrupted by the pandemic, Bryan shares how Adarza responded to the challenge by utilizing Ziva for COVID-19 research. Hosted on Acast. See acast.com/privacy for more information.2020-12-0235 minConversations in HealthcarePossible treatment for COVID-19 related respiratory failureIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Jonathan Javitt, CEO of NeuroRx. Dr Javitt discusses how NeuroRx is working in collaboration with Relief Therapeutics on Aviptadil, a synthetic version of vasoactive intestinal peptide, and a potential treatment of COVID-19 related respiratory failure. Dr. Javitt shares the promising results of an open label study of the drug, and the company’s plans if trials are successful. Hosted on Acast. See acast.com/privacy for more information.2020-12-0221 minConversations in HealthcareTransforming the treatment of cancer with oncolytic virusesIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Stephen Russell, CEO of Vyriad. Dr. Russell reveals invaluable insights for those looking for or currently putting together partnership deals. Stephen shares his journey from academia at the Mayo Clinic to founding Vyriad, and eventually partnering with Regeneron for the development of new oncolytic virus treatments for cancer. Learn how Vyriad pivoted their technology to develop antibody tests for COVID-19 during the crisis. Hosted on Acast. See acast.com/privacy for more information.2020-12-0233 minConversations in HealthcareEarly planning key to successful access and product launchIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Alison Kneen, Senior Vice President, Global Market Access and Head of the Centre of Innovation and Regulatory Science (CIRS) and DRG Abacus. Learn why early and thorough planning is so important for a successful product launch, and how Alison and her team helped one client avoid major pitfalls, even when the odds were stacked against them. Hosted on Acast. See acast.com/privacy for more information.2020-12-0229 minConversations in HealthcareCOVID-19, multi-stem clinical trials and a new way of fundraisingIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Gil Van Bokkelen, founder, chairman and CEO of Athersys Inc. They discuss the company’s clinical program that is focusing on a special class of stem cells which display very unique properties and have been obtained from healthy young consenting donors. Mike and Gil talk about how Athersys was already working on an approach to treat patients with acute respiratory distress syndrome before the pandemic emerged and the challenges they face to tackle their COVID-19 strategy. Also, Gil shares how Athersys was successful in ra...2020-12-0250 minConversations in HealthcareThe past, present and future of next generation sequencingIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Nick McCooke, CEO of Longas Technologies. Having been at the forefront of developing next generation sequencing, Nick talks to Mike about his past work, current projects and future predictions for this key technology in the life sciences space. He explains the process and journey he went on to trigger the creation of Solexa, which was later acquired by Illumina, and how next generation sequencing developed and transformed the marketplace after this acquisition. Nick also explains the role NGS...2020-12-0230 minConversations in HealthcareHow Glympse Bio oversubscribed their Series B funding amidst the pandemicIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Dr. Caroline Loew, President and CEO from Glympse Bio. They discuss the biotech’s focus on both disease detection and response to treatment using bioengineered sensors, starting with NASH. Dr. Loew also shares career advice for moving from pharma to biotech and how she pivoted the company’s narrative during a funding round at the bottom of the pandemic-related stock market crash. Hosted on Acast. See acast.com/privacy for more information.2020-12-0244 minConversations in HealthcareA novel approach to treating neurodegenerative diseaseIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Dr. Leen Kawas, president and CEO of Athira Pharma. Dr. Kawas shares the company’s innovative approach to treating Alzheimer’s disease by developing small molecules to restore neuronal health and stop neurodegeneration. They also discuss Athira’s recent IPO following a successful series B funding round, all during the pandemic. Hosted on Acast. See acast.com/privacy for more information.2020-12-0226 minConversations in HealthcareAn update from biopharma’s hotspotIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, Part of Clarivate talks to Bob Coughlin, president and CEO of the Massachusetts Biotechnology Council. Bob provides insights from what is unarguably the world’s number one biopharma hotspot. Bob and Mike discuss how the industry has collaborated to counter the most immediate issues the COVID-19 pandemic has raised and how these could inform the future of biopharma. Bob also talks passionately about how partnering with patient groups is key to patient centricity to truly understand the real unmet patient ne...2020-12-0227 minConversations in HealthcareAddressing strategic challenges for biotech companiesIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, talks to Dr Srikanth Rajagopal (or Doc, as he is fondly referred to). Doc, a partner at DRG Consulting, whose areas of expertise include product and portfolio strategy to name a few, chatted to us about common strategic challenges biotechnology companies face during the process of translating a discovery into a tangible medicine. Doc gives invaluable insight for bio-pharma companies who are making development and/or commercializing decisions for their clinical programs both for those developing in house and those considering out licensing. He...2020-11-1830 minConversations in HealthcareCollaborating with officials to continue developmentsIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Joe Panetta, President and CEO of BIOCOM. Joe talks around how BIOCOM has worked closely with government officials to ensure the life science community can continue to function throughout the COVID-19 pandemic, and how they’ve worked with these officials to develop guidance for this community on how they can safely return to work. Joe discusses how COVID-19 has affected funding for biotech companies, the ability to build international relationships with global companies and how new digital practices su...2020-11-1839 minConversations in HealthcareHow including patients can help with the fight against Parkinson’s DiseaseIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Charlotte Allen and Russ Bradford from Parkinson’s Concierge. Russ and Charlotte offer a unique insight into how being a patient centric organisation enables them to help the Parkinson’s Disease community improve their quality of life and understanding of the disease. They talk about the work they’re currently doing to educate the community and their newest partnership with ReMeLife to expand their network globally. As the disease affects each patient differently, they work to raise awareness to org...2020-11-1821 minConversations in HealthcareMaximising R+D efforts through better epidemiology understandingIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, talks to Mike Hughes, Senior Director of Epidemiology at DRG. With epidemiology entering our daily vernacular, thanks to the Covid-19 pandemic, Mike gives a definition of what it is, the approaches used to model epidemiology associated with diseases and how it’s beneficial across all stages of research and development in pharma. In particular, they talk about the value epidemiology can bring to decision making and how it can aid in maximizing R&D efforts and investment decisions surrounding pipeline de...2020-11-1823 minConversations in HealthcareBringing together minds to combat COVID-19In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Sir Mene Pangalos, Executive Vice President at AstraZeneca. Sir Mene talks to Mike about AstraZeneca's learnings from helping Chinese colleagues combat Coronavirus at the end of 2019, and then expanding input as it became a global issue. This includes adapting existing molecules in their pipeline, utilizing their existing capabilities and keeping their supply chain moving. He also explains how the industry has come together like never before to collaborate and share ideas across the board. Sir Mene and Mike...2020-11-1827 minConversations in HealthcareAn unprecedented time of scientific innovationIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, talks to Houman Ashrafian, Managing Partner at SV Health Investors. Houman gives an interesting perspective into how and why biotech investment has remained robust throughout the Covid-19 pandemic. He talks to Mike about his proven track record for establishing companies and the factors he looks for when identifying interesting, investable science. Houman also talks about his work on the Dementia Discovery Fund investment committee, the opportunities they look for as well as the lessons the industry can learn from the...2020-11-1839 minConversations in HealthcareSecuring investments amidst COVID-19 and Brexit uncertaintiesIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Hakan Goker, Vice President of M Ventures. Hakan gives a unique insight into how both COVID-19 and Brexit are affecting current investment opportunities for both investors and start-ups, including restrictions on travel, face to face pitching and pipeline requirements. He talks about the increasing importance on making sure all written communications and presentations are clear and sharp in this era to help executives secure and access finance, as well as patience while VC’s focus on existing partnerships. Ha...2020-11-1833 minConversations in HealthcareThe advantages of onsite manufacturing facilities for clinical trialsIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Bill Newell, CEO of Sutro Biopharma. Bill shared his views on the fundamental importance of ensuring patients, especially cancer patients, receive their treatment (as scheduled) despite pandemic related delays. He explained how they were uniquely positioned to continue trials and initial new ones safely and with minimal interruption due in large part to their onsite manufacturing facilities. Mike and Bill talked about how Sutro Biopharma successfully raised $98 million in a public offering through zoom calls which pre-pandemic would have been unheard of! They also...2020-11-1836 minConversations in HealthcareBringing new medicines to market despite subjective endpointsIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Seth Lederman, co-founder, CEO and chairman of Tonix Pharmaceuticals. Seth and Mike explored the two programs Tonix are currently developing in pain and psychiatry, areas where many larger companies have turned their back due to subjective endpoints. Tonix believes they have developed invaluable expertise to counter these challenges and Seth explains that the difficulty of the endpoints, will be compensated by the importance of bringing new medicines to market that will be significant to the pharmacopeia. Tonix is...2020-11-1831 minConversations in HealthcareRevolutionising the neurodegenerative space – fundraising, development & beyondIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Sanjay Kakkar, CEO of San Francisco Bay-based start-up Tranquis Therapeutics. The company focuses on neurodegenerative diseases, an area where significant unmet medical need remains and that has presented the life sciences sector with major challenges for many years. Undaunted, Tranquis Therapeutics has successfully raised $30m in series A for their lead compound. In this interview Sanjay shares the milestones involved in both the development of their compelling compounds that are set to revolutionise the space, as well as...2020-11-1821 minConversations in HealthcareHow COVID is reshaping global policy and what it means for market accessIn response to the pandemic, governments around the world have instituted policy changes intended to mitigate the impact of the coronavirus that could have long-lasting impacts. In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to DRG market access experts Steve Edgar and Judith Rubinstein about how new policies are reshaping supply chains, testing, development, approval and care delivery – and what it means for life sciences executives. Hosted on Acast. See acast.com/privacy for more information.2020-11-1839 minConversations in HealthcareHow innovation can continue to evolve and shape the pharma spaceIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Daphne Zohar, Founder and CEO of PureTech. Daphne sheds light on how their unique and innovative business model looks to solve unmet needs and problem areas across the industry, how they differ from your typical biotech and the benefit of their problem centric approach. She explores how they’re constantly innovating their internal pipeline and adapting to the needs of the market, such as using LYT-100, an existing program, to treat post-recovery complications from COVID-19. Daphne also shares he...2020-11-1830 minConversations in HealthcareHow China has grown through innovation to rival the US marketIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Christian Hogg, Executive Director and CEO of Chi-Med, about how the pharmaceutical and biotech industry in China has shifted its priorities from generic medicines to more innovative therapies. Christian talks in depth around the driving factors and investment in innovation, including a reform of the regulatory environment and the vast expansion of access to patients. He also gives his take on why he believes some multi-national companies prosper, and why some fail, when trying to enter the Chinese biotech and pharmaceutical markets, and what...2020-11-1829 minConversations in HealthcareUsing a problem centric approach to build programsIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Eric Elenko, Chief Innovation Officer of PureTech. Eric provides a unique insight into how they use a problem centric approach to identify and build out treatment programs, both internally and through their own founded entities. Eric also explains how this model has inspired them to repurpose one of their existing programs, LYT-100, to help solve the issue of pulmonary complications in recovering COVID-19 patients. He also talks about the affect social distancing has had on the industry, stating...2020-11-1834 minConversations in HealthcareBecoming one of the leaders in developing COVID-19 diagnosticsIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Mark Stevenson, Vice President and Chief Operations Officer at Thermo Fisher Scientific. Mark talks to Mike about day-to-day pandemic effects on operations and priorities, and how they have redistributed resources to help combat impact and maintain longer-term business focus. He also explores how he feels the pandemic will change supply chains moving forward, as well as the life science ecosystem in general. Mark goes on to discuss exciting new developments for his company, including their bid to acquire...2020-11-1832 minConversations in HealthcareWill healthcare change after COVID-19?In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Richard Erwin, General Manager and Managing Director of Roche Products Ltd (UK). Mike and Richard discuss what companies can learn from the pandemic and if the business world will operate the same way as before. Richard shared how they sped up their clinical trial lead time, from initial discussions through to first patient, to under a month (normally this could take a year)! Richard also talks about the new ways of doing things in healthcare such as telephone...2020-11-1843 minConversations in HealthcareThe pandemic, politicians and scienceIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Baroness Susan Greenfield, founder and CEO of Oxford-based start-up Neuro-bio. Susan and Mike discuss the impacts of COVID-19 in the workplace and how the new stay-at-home policy has put a pause on projects. As a member of the House of Lords, Susan was also able to explore and share her views on the dynamics between politicians and science. Hosted on Acast. See acast.com/privacy for more information.2020-11-1827 minConversations in HealthcareThe effects of COVID-19 on worldwide oncology clinical trialsIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Steve Fruchtman, President and CEO of Onconova Therapeutics Inc, about how the reallocation of resources within cancer centres around the world due to COVID-19. Steve talked us through the impacts on their early and late stage lead programs which includes short term restrictions such as accessing review data, as well as longer-term impacts including additional monitoring and testing for patients on haematology and oncology trials. Steve gives an insight into how they’re preparing for commercialization of their therapies within China, the affect COVID-19 ha...2020-11-1728 minConversations in HealthcareCOVID-19 continues to disrupt patient careIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to John Jaeger, a partner at DRG on how COVID-19 is disrupting access to care. John talks us through the results from a recent physician survey, about current limitations on access to treatment including how patients are responding to the shift from in-facility treatment to home-administered treatments. John and Mike also discuss the implications of the “warehousing” effect that will take place and continue to disrupt the space caused by patients waiting to receive care or delaying treatment until the pandemic eases. They also speculate whic...2020-11-1726 minConversations in HealthcareTo know COVID-19 is to know medicineIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Dr. RJ Tesi, CEO of INmune Bio about its clinical program that seeks to determine whether its existing TNF inhibitors can be repurposed to prevents complications of cytokine storm caused by COVID-19. Dr. Tesi gives solemn insight into trial design, endpoint selection, FDA application as well explaining how INmune is “messing” with the pathology of COVID-19, not only to treat its symptoms but to treat the disease itself. Dr. Tesi takes us through the evolving landscape of secondary complications caused by COVID-19 and...2020-11-1441 minConversations in HealthcareImpact of COVID-19 on the development of CAR T-cell therapiesIn this episode of Conversations in healthcare, Mike Ward, Global Head of Thought Leadership talks to Dana Gheorghe, Ph.D, Associate Director, Oncology, about the impact COVID-19 is having on treatment for already available CAR T-cell therapies as well as those being developed. Dana gives us the lay of the land in an area where there is scarcity of information that is frequently changing. Dana covers how patients are being prioritised according to risk and need at this time and the challenges of getting high risk patient profiles much needed treatments. She also discusses the various country and region-specific conditions...2020-11-1326 minConversations in HealthcareWuhan experience shapes the new normal for healthcareIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Christian Hogg, CEO of Hutchison China MediTech about how the organisation has tackled the impacts of COVID-19 on business globally. Christian gives us a month-by-month account from January to May of how they mitigated disruption and moved to a place of “new normal”, most notably within business activities related to commercial operations and getting vital medication to patients on clinical trials. With China slightly ahead of the pandemic curve from a timing perspective, what takeaways can the rest of the world utilise to ensu...2020-11-1327 minConversations in HealthcareCreating a collaborative toolbox to fight COVID-19In this episode of Conversations in Healthcare, Mike Ward talks to Werner Lanthaler, CEO of Evotec, about how COVID-19 is bringing pharma leaders together and giving them collaborative momentum. Dr. Lanthaler is a co-founding member of COVID R&D, a global pharma industry initiative that has come together to rapidly respond to the pandemic. Together they are fast-tracking learnings and protocols to create a toolbox that can accelerate activities like clinical trials, re-purposing compounds and data sharing to address the crisis faster. COVID-19 has brought barriers down and truly brought the healthcare industry together, but could this forced synergy and...2020-11-1333 minConversations in HealthcarePivoting a product launch during the pandemicIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership speaks with Bryan Witherbee, President & CEO of Adarza BioSystems. Earlier this year, Adarza raised 25 million dollars to support the full commercialization of Ziva, an automated biological platform which delivers comprehensive, high definition, protein biomarker profiles. Although their launch plans were disrupted by the pandemic, Bryan shares how Adarza responded to the challenge by utilizing Ziva for COVID-19 research. Learn more in the full episode. Hosted on Acast. See acast.com/privacy for more information.2020-10-0235 min